Insiders · INM

INM insider transactions

InMed Pharmaceuticals Inc. (INM) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for INM

• 13d
  Large owner Adar1 Capital Management, Llc bought $721,548 worth of shares (468,551 units at $1.54) (SEC Form 4)

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 13d
  New insider Adar1 Capital Management, Llc claimed ownership of 331,449 shares (SEC Form 3)

  3 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 166d
  SEC Form 4 filed by Sr VP & General Manager Johnson Shane Aaron

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 166d
  SEC Form 4 filed by Director Lemerond Nicole

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 166d
  SEC Form 4 filed by Director Klompas Neil A

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 166d
  SEC Form 4 filed by Chief Financial Officer Jagpal Netta

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 166d
  SEC Form 4 filed by Chief Operating Officer Woudenberg Michael

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 166d
  SEC Form 4 filed by Director Bathery John Steven

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 166d
  SEC Form 4 filed by Sr. VP, Pre-Clinical Res/Dev Hsu Eric C

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 166d
  SEC Form 4 filed by President & CEO Adams Eric A

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 166d
  SEC Form 4 filed by Director Hull Andrew

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 168d
  SEC Form 4 filed by Director Hull Andrew

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 168d
  SEC Form 4 filed by President & CEO Adams Eric A

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 168d
  SEC Form 4 filed by Chief Operating Officer Woudenberg Michael

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 168d
  SEC Form 4 filed by Sr. VP, Pre-Clinical Res/Dev Hsu Eric C

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 223d
  SEC Form 3 filed by new insider Bathery John Steven

  3 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 225d
  SEC Form 4 filed by Director Klompas Neil A

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 229d
  SEC Form 3 filed by new insider Klompas Neil A

  3 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 485d
  SEC Form 4 filed by Director Hull Andrew

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 527d
  SEC Form 4 filed by Sr VP & General Manager Johnson Shane Aaron

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 527d
  SEC Form 4 filed by Chief Financial Officer Jagpal Netta

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 527d
  SEC Form 4 filed by Director Lemerond Nicole

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 527d
  SEC Form 4 filed by Chief Operating Officer Woudenberg Michael

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 527d
  SEC Form 4 filed by Director Grove Janet P

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 527d
  SEC Form 4 filed by Sr. VP, Pre-Clinical Res/Dev Hsu Eric C

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 527d
  SEC Form 4 filed by President & CEO Adams Eric A

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 527d
  SEC Form 4 filed by Director Baldasare Bryan T

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 527d
  SEC Form 4 filed by Director Hull Andrew

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 670d
  Consultant Mancini Alexandra Diane Janet sold $42 worth of shares (240 units at $0.18), closing all direct ownership in the company (SEC Form 4)

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 736d
  SEC Form 4 filed by Woudenberg Michael

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 736d
  SEC Form 4 filed by Adams Eric A

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 736d
  SEC Form 4 filed by Hsu Eric C

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 820d
  SEC Form 4 filed by Hull Andrew

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 820d
  SEC Form 4 filed by Hsu Eric C

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 820d
  SEC Form 4 filed by Mancini Alexandra Diane Janet

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 827d
  SEC Form 3 filed by new insider Jagpal Netta

  3 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 832d
  Hull Andrew bought $14,625 worth of shares (37,500 units at $0.39), increasing direct ownership by 4,947% to 38,258 units (SEC Form 4)

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 833d
  Adams Eric A bought $14,922 worth of shares (41,600 units at $0.36), increasing direct ownership by 1,763% to 43,959 units (SEC Form 4)

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 890d
  SEC Form 4 filed by Johnson Shane Aaron

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 890d
  SEC Form 4 filed by Lemerond Nicole

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 890d
  SEC Form 4 filed by Woudenberg Michael

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 890d
  SEC Form 4 filed by Tegge Jonathan

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 890d
  SEC Form 4 filed by Grove Janet P

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 890d
  SEC Form 4 filed by Hsu Eric C

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 890d
  SEC Form 4 filed by Adams Eric A

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 890d
  SEC Form 4 filed by Baldasare Bryan T

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 890d
  SEC Form 4 filed by Mancini Alexandra Diane Janet

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 890d
  SEC Form 4 filed by Hull Andrew

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 910d
  SEC Form 4 filed by Woudenberg Michael

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 1007d
  SEC Form 4 filed by Hsu Eric C

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 1114d
  SEC Form 4 filed by Hsu Eric C

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 1114d
  SEC Form 4 filed by Mancini Alexandra Diane Janet

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 1114d
  SEC Form 4 filed by Adams Eric A

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 1182d
  SEC Form 4 filed by Mancini Alexandra Diane Janet

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 1182d
  SEC Form 4 filed by Hsu Eric C

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 1182d
  SEC Form 4 filed by Adams Eric A

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 1262d
  SEC Form 4 filed by Lemerond Nicole

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 1262d
  SEC Form 4 filed by Tegge Jonathan

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 1262d
  SEC Form 4 filed by Li Sarah

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)
• 1262d
  SEC Form 4 filed by Johnson Shane Aaron

  4 - InMed Pharmaceuticals Inc. (0001728328) (Issuer)